Help Ensure Safe Transitions of Care for Pulmonary Hypertension Patients
It's getting harder to keep up with medications for pulmonary hypertension...especially with more patients on combination therapy.
Help ensure safe transitions of care for these patients.
Continue most meds on admission. Avoid interruptions in prostacyclin therapy...especially IV epoprostenol (Flolan, Veletri, etc) and treprostinil (Remodulin) continuous infusions. Abruptly stopping these can lead to life-threatening rebound pulmonary hypertension.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote